Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at a drug called UCB4594 for cancer that has spread

Overview

Cancer types:

Bowel (colorectal) cancer, Breast cancer, Cervical cancer, Head and neck cancers, Kidney cancer, Lung cancer, Non small cell lung cancer (NSCLC), Oesophageal cancer, Ovarian cancer, Pancreatic cancer, Renal cell cancer, Secondary cancers

Status:

Open

Phase:

Phase 1/2

Details

This trial is looking at a drug called UCB4594 by itself and in combination with other treatments for solid cancers that have spread (advanced cancer).

It is open to people whose treatment has stopped working and there is no standard treatment available.

Recruitment start: 9 July 2024

Recruitment end: 28 February 2029

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Fiona Thistlewaite

Supported by

Cancer Research UK

Centre for Drug Development

UCB Biopharma SRL

Other information

This is Cancer Research UK trial number CRUKD/24/001.

Last reviewed: 20 March 2025

CRUK internal database number: 19883

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.